ArticleFrontiers in public health2025
Effects of DRG/DIP payment reform on hospital pharmacy administration and pharmaceutical services in China: a multicenter cross-sectional study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Trial
- The Impact of DRG Review Teams on Obstetric Disease Management and Cost Control: A Variance Analysis Approach.The journal of obstetrics and gynaecology research · 2026Article
- Impact of diagnosis-intervention packet payment reform on pediatric hospital services: an interrupted time series analysis.BMC health services research · 2026Article
- Dynamic evaluation and continuous improvement model of pharmaceutical administration based on DPSIR-TOPSIS.BMC health services research · 2026Article
- Heterogeneous stock market responses to pharmaceutical policy events across subsectors and time scales: Evidence from China.PloS one · 2026Article
- Article
- Transforming long-term post-acute care for the aging population through home infusion therapy in China: an assessment of need and demand (Part 1).Frontiers in public health · 2026Review
- Risk Governance of Payment Exceptions Under China's DRG/DIP Reform: A Structured Policy-Text Analysis of Special Case Negotiation Rules.Risk management and healthcare policy · 2026Article
- Direct hospitalization costs of children withFrontiers in public health · 2026Article
- Determinants of hospitalization expenditure for pediatric congenital heart disease: a single-center study from Xinjiang, China.Frontiers in public health · 2025Article
- The impact of a deep vertical medical alliance on enhancing clinical capacity and reversing patient outflow at a Chinese county hospital: a 4-year case study.Frontiers in health services · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In China, a government-led policy introduced in 2019 and 2020 aims to reduce medical costs through a national medical care payment system based on Diagnostic-Related Groups (DRG) and Diagnosis-Intervention Packet (DIP). Hospital pharmacists play a crucial role in the implementation of this policy by enhancing the rational use of medicines and delivering pharmaceutical services. The purpose of this study is to assess the current state of hospital pharmacy administration and pharmaceutical services, while examining the effects of the DRG/DIP policy on these aspects. Methods: This multicenter cross-sectional study utilized a questionnaire survey to collect data. The questionnaire consisted of four main parts: participants' demographics, hospital and DRG/DIP payment information, hospital pharmacists' involvement in pharmacy administration and pharmaceutical services, and barriers and suggestions encountered in their work. The questionnaire was distributed to pharmacy department heads in hospitals across mainland China through convenience sampling, between September 2022 and December 2022. Multivariate logistic regression analysis was performed to identify factors associated with hospital pharmacy administration and pharmaceutical services. Results: A total of 655 pharmacists from 655 hospitals participated in the questionnaire survey. Pharmacists in DRG/DIP implemented hospitals were more involved in both pharmacy administration and pharmaceutical services compared to those in non-DRG/DIP implemented hospitals. The DRG/DIP reform was associated with improved hospital pharmacy administration (OR = 1.87, 95% CI 1.26-2.77, Conclusions: To effectively adapt the healthcare payment reform, it is suggested that the pharmacy department should adopt DRG/DIP as a strategic focus, continuously enhance pharmaceutical services capabilities and pharmacy administration systems, and achieve value optimization within the context of healthcare payment reform.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.